U.S. market Closed. Opens in 11 hours 44 minutes

ADXN | Addex Therapeutics Ltd Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Revenue1.61M1.42M2.92M3.61M2.76M6.04MN/AN/AN/AN/AN/AN/A2.82M1.98M4.09M26.81M486.93K4.74M
Cost of Revenue6.94M14.62M12.82M10.37M230.10K144.17K29.76K17.33K40.30K85.40K91.76K1.27M27.99MN/AN/AN/AN/AN/A
Gross Profit-5.32M-13.20M-9.90M-6.76M2.53M5.90M-29.76KN/AN/AN/AN/A-1.27M-25.16MN/AN/AN/AN/AN/A
Operating Expenses11.89M21.94M18.42M15.86M17.37M7.47M3.24M3.14M2.64M1.80M14.46M27.01M5.81M35.57M47.56M51.68M38.11M25.76M
Selling, General & Admin7.20M7.30M5.14M5.15M4.26M4.72M2.20M1.52M1.57M1.55M6.47M12.85M6.73M6.43M7.60M7.55MN/AN/A
Research & Development2.75M14.67M12.84M10.37M12.45M2.37M841.31K819.33K761.22K258.06K2.22M4.76MN/A31.16M39.96M44.19M12.21M9.77M
Other Operating ExpensesN/A-22.52K444.00K336.68K648.16K382.99K197.67K799.70K311.82K-9.44K5.77M9.40M-919.55K-2.02MN/A-67.33K25.90M15.98M
Operating Income-10.28M-20.52M-15.51M-12.24M-14.83M-1.42M-3.24M-3.14M-2.64M-1.80M-14.46M-27.01M-30.97M-33.60M-43.47M-24.87M-37.62M-21.02M
Other Expenses / Income-317.29K-284.01K154.00K-615.33K53.70K-220.17K-45.35K-8.01K-1.56M21.68K-3.23K-8.41K-167.17K-47.56K86.16M2.81M2.54M472.32K
Before Tax Income-10.56M-20.80M-15.35M-12.86M-14.78M-1.64M-3.28M-3.15M-4.20M-1.77M-14.46M-27.02M-31.14M-33.65M42.69M-22.07M-35.09M-20.54M
Income Tax Expenses21.61K123.91K116.38K207.76K429.01K1.00N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-10.56M-20.80M-15.35M-12.86M-14.78M-1.64M-3.28M-3.15M-4.20M-1.77M-14.46M-27.02M-31.14M-33.65M-42.69M-22.07M-35.09M-20.54M
Interest Expenses21.61K48.90K63.01K69.50K128.52K220.17K45.35K6.92K152.21KN/AN/AN/A239.37K144.81KN/A501.88K8.54K30.45K
Basic Shares Outstanding74.31M45.18M34.12M26.68M26.43M23.29M2.16M1.90M1.81M1.66M1.51M1.32M1.24M986.06K955.78K956.03K836.15K476.53K
Diluted Shares Outstanding74.31M45.18M34.12M26.68M26.43M23.29M2.16M1.90M1.81M1.66M1.51M1.32M1.24M986.06K955.78K956.03K836.15K476.53K
EBITDA-9.91M-20.17M-15.15M-11.83M-14.23M-1.42M-3.22M-3.12M-2.61M-1.71M-13.79M-24.87M-27.97M-30.56M-39.86M-19.55M-33.28M-17.99M
EBITDA Margin-614.49%-1,417.83%-519.59%-327.42%-515.18%-23.52%0.00%0.00%0.00%0.00%0.00%0.00%-990.78%-1,547.10%-974.30%-72.92%-6,833.66%-379.66%
EBIT-10.51M-20.63M-15.17M-12.58M-14.22M-1.42M-3.24M-3.14M-4.05M-1.77M-14.46M-27.02M-30.90M-33.50M-42.69M-21.56M-35.08M-20.51M
EBIT Margin-651.79%-1,450.43%-520.26%-348.24%-514.80%-23.57%0.00%0.00%0.00%0.00%0.00%0.00%-1,094.47%-1,696.00%-1,043.62%-80.44%-7,203.75%-432.89%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙